His scientific interests lie mostly in Immunology, Systemic lupus erythematosus, Lupus erythematosus, Internal medicine and Genetics. His Immunology research incorporates themes from Odds ratio, Single-nucleotide polymorphism and Haplotype. His Systemic lupus erythematosus study integrates concerns from other disciplines, such as Congenic, Histone, Proteinuria and Cohort.
The study incorporates disciplines such as Mesangial cell, Genetic predisposition and Risk factor in addition to Lupus erythematosus. The various areas that Gary S. Gilkeson examines in his Internal medicine study include Gastroenterology and Endocrinology. Gary S. Gilkeson has researched Lupus nephritis in several fields, including Glomerulonephritis, Surgery, Cyclophosphamide and Kidney disease.
Immunology, Systemic lupus erythematosus, Internal medicine, Lupus erythematosus and Endocrinology are his primary areas of study. His biological study spans a wide range of topics, including Lupus nephritis and Single-nucleotide polymorphism. His study in Systemic lupus erythematosus is interdisciplinary in nature, drawing from both Autoimmunity, Nephritis, Pathogenesis and Cohort.
He has included themes like Gastroenterology and Mesenchymal stem cell in his Internal medicine study. His studies in Lupus erythematosus integrate themes in fields like Odds ratio, Epidemiology, Case-control study, Connective tissue disease and Risk factor. His work carried out in the field of Endocrinology brings together such families of science as Spleen and Receptor.
Gary S. Gilkeson spends much of his time researching Immunology, Systemic lupus erythematosus, Internal medicine, Autoimmunity and Immune system. His Immunology research is multidisciplinary, incorporating perspectives in Single-nucleotide polymorphism, Case-control study and Disease. The concepts of his Single-nucleotide polymorphism study are interwoven with issues in Genetic variation, Haplotype and Candidate gene.
Gary S. Gilkeson combines subjects such as B cell, Sex hormone-binding globulin, Testosterone, Lupus nephritis and Transplantation with his study of Systemic lupus erythematosus. His Internal medicine research integrates issues from Lupus erythematosus, Endocrinology and Umbilical cord. His Immune system study incorporates themes from Homeostasis, Inflammation, Proinflammatory cytokine and Biochemistry, Signal transduction.
Gary S. Gilkeson mainly investigates Internal medicine, Immunology, Autoimmunity, Genetics and Immune system. His work deals with themes such as Gastroenterology, Endocrinology and Messenger RNA, which intersect with Internal medicine. All of his Immunology and Lupus erythematosus and Autoantibody investigations are sub-components of the entire Immunology study.
The Autoimmunity study combines topics in areas such as Systemic lupus erythematosus and B cell. His research in Systemic lupus erythematosus intersects with topics in Gene knockout, Lupus nephritis and Pathogenesis. Gary S. Gilkeson works mostly in the field of Immune system, limiting it down to topics relating to Disease and, in certain cases, B-cell activating factor, as a part of the same area of interest.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Human polymorphism at microRNAs and microRNA target sites.
Liuqing Yang;Chunru Lin;Chunyu Jin;Joy C. Yang.
Frontiers in Genetics (2013)
Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci.
John B. Harley;John B. Harley;John B. Harley;Marta E. Alarcón-Riquelme;Lindsey A. Criswell;Chaim O. Jacob.
Nature Genetics (2008)
Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis
Ellen M. Ginzler;Mary Anne Dooley;Cynthia Aranow;Mimi Y. Kim.
The New England Journal of Medicine (2005)
Mycophenolate Mofetil versus Cyclophosphamide for Induction Treatment of Lupus Nephritis
Gerald B. Appel;Gabriel Contreras;Mary Anne Dooley;Ellen M. Ginzler.
Journal of The American Society of Nephrology (2009)
Vitamin D deficiency in systemic lupus erythematosus.
Diane L. Kamen;Glinda S. Cooper;Henda Bouali;Stephanie R. Shaftman.
Autoimmunity Reviews (2006)
Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus
Lingyun Sun;Dandan Wang;Jun Liang;Huayong Zhang.
Arthritis & Rheumatism (2010)
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study
Jun Liang;Huayong Zhang;Bingzhu Hua;Hong Wang.
Annals of the Rheumatic Diseases (2010)
Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains
Laurence Morel;Byron P. Croker;Kim R. Blenman;Chandra Mohan.
Proceedings of the National Academy of Sciences of the United States of America (2000)
Lack of a Functional Alternative Complement Pathway Ameliorates Ischemic Acute Renal Failure in Mice
Joshua M. Thurman;Danica Ljubanovic;Charles L. Edelstein;Gary S. Gilkeson.
Journal of Immunology (2003)
A nonsynonymous functional variant in integrin-alpha(M) (encoded by ITGAM) is associated with systemic lupus erythematosus.
Swapan K. Nath;Shizhong Han;Xana Kim-Howard;Jennifer A. Kelly.
Nature Genetics (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Cincinnati Children's Hospital Medical Center
Oklahoma Medical Research Foundation
Cincinnati Children's Hospital Medical Center
University of Granada
University of Oklahoma Health Sciences Center
Oklahoma Medical Research Foundation
Oklahoma Medical Research Foundation
University of Alabama at Birmingham
King's College London
Wake Forest University
Rutgers, The State University of New Jersey
Southwestern University of Finance and Economics
National Yang Ming Chiao Tung University
University of Hong Kong
University of Cambridge
Wuhan University
TU Dresden
King's College London
The University of Texas Southwestern Medical Center
Monash University
Yale University
Oregon Health & Science University
University Hospitals of Cleveland
King's College London
University of Oxford
Max Planck Society